Sang T. Kim, MD, PhD
Department of General Internal Medicine, Division of Internal Medicine
Education & Training
Degree-Granting Education
| 2014 | Yale Graduate School of Arts and Sciences, New Haven, CT, USA, PHD, Human Immunology |
| 2003 | Yonsei University College of Medicine, Seoul, KOR, MD, Medicine |
Postgraduate Training
| 2016-2016 | Visiting Scientist, Section of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2015-2015 | Research Fellowship, Section of Rheumatology, Yale University School of Medicine, New Haven, CT |
| 2009-2015 | Clinical Fellowship, Section of Rheumatology, Yale University School of Medicine, New Haven, CT |
| 2009-2014 | Research Fellowship, Section of Rheumatology, Yale University School of Medicine, New Haven, CT |
| 2006-2009 | House Staff, Mount Sinai School of Medicine at Queens Hospital Center, Queens, NY |
| 2005-2006 | Research Fellowship, Fred Hutchinson Cancer Research Center, Seattle, WA |
| 2004-2004 | Research Fellowship, Yonsei University College of Medicine, Seoul |
Board Certifications
| 2016 | ABIM Rheumatology |
| 2009 | ABIM Internal Medicine |
Experience & Service
Academic Appointments
Instructor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2019
Institutional Committee Activities
Member, IOTOX Preclinical Research Working Group, 2018 - Present
Member, IOTOX Clinical Trials Working Group, 2018 - Present
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Bedrose S, Turin CG, Lavis VR, Kim ST, Thosani SN. A Case of Acquired Generalized Lipodystrophy Associated with Pembrolizumab in a Patient With Metastatic Malignant Melanoma. AACE Clin Case Rep 6(1):e40-e45, 2020. e-Pub 2020. PMID: 32524008.